28.08.2018 • NewsBASFDede WillamsGrolman

Grolman and BASF extend Distribution Pact

Grolman and BASF extend Distribution Pact (c) BASF
Grolman and BASF extend Distribution Pact (c) BASF

German chemicals distributor Gustav Grolman has expanded its distribution pact for BASF’s Baxxoduramine-based curing agents used in processing epoxy resin to markets in Italy, Spain and Portugal.

Since 2015, the two companies have cooperated exclusively in the marketing of Baxxodur in Europe, with the initial agreement covering France, Norway, Sweden, Finland and Denmark.

Privately owned Grolman regards itself as one of Europe's largest distributors of specialty chemicals with diversified knowhow in application technology, and the company said the extended partnership with BASF will further strengthen its position.

Grolman said the curing agent components used in epoxy resin-based applications such as thermosetting laminates, highly resistant floor coatings, corrosion protection varnish and composite materials supplement its own portfolio of resins, accelerators, additives, flame retardants, pigments and special fillers for the thermosetting industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.